Medical device CRO Factory buys MileStone Research Organization for North America expansion

U.S. roadmap
Medical devices-focused CRO Factory has expanded in North America with the acquisition of Milestone.

The Netherlands-based medical devices-focused CRO Factory has acquired Milestone Research Organization, expanding its footprint in North America.

“MileStone is an excellent fit therapeutically, as well as culturally,” said Factory CEO Dirk Meijer, M.D., Ph.D., in a statement. “Milestone’s extensive expertise in orthopedics, neurological and IVD clinical trials, as well as their reimbursement and site management service offerings, is a fantastic value-add for all our clients.”

What’s more, the addition of San Diego-based Milestone builds on Factory’s existing U.S. presence in Austin, Texas, and Princeton, New Jersey. Besides California, the company now has branches in Minnesota and the city of Chicago.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Operational in over 20 countries worldwide, Factory now offers medical device companies services in data management, consultancy regarding study design and budget and regulatory strategy, regulatory filings, clinical trial monitoring and reimbursement.

Since 1992, the company has completed more than 450 projects in Class II and Class III medical devices and in vitro diagnostic device (IVD), which span a wide range of therapeutic areas, including abdominal, cardiovascular, bone and joint and cardiothorax surgery, as well as interventional radiology, urology, diabetes and dermatology, etc.

According to Factory’s webpage, MileStone founder Kevin Liang, Ph.D., has transitioned to the role of chief clinical officer within the company.

Suggested Articles

The FDA approved a new, tiny pacemaker from Medtronic that does not require the wiring of separate electrodes between the implant and the heart.

Bayer CEO Werner Baumann stressed “less and less trust in society" for technology advances as a hurdle for pharma companies working on gene editing.

The respiratory care company Vyaire Medical has brought on a new CEO, Gaurav Agarwal, following a year of new product launches.